Takeda stakes more than $11B on cancer drugs from China

The Japanese pharma is licensing up to three next-generation cancer drugs from Innovent Biologics in a deal it believes to be “transformative” for its oncology portfolio.

GROW Project launched to drive green jobs, sustainable construction in Africa – EnviroNews

February 26, 2026

Lilly to give biotech startups access to AI tools

Lilly’s GLP-1 pill tops Novo’s Rybelsus in head-to-head trial

February 26, 2026

Source link

Takeda stakes more than $11B on cancer drugs from China

GROW Project launched to drive green jobs, sustainable construction in Africa – EnviroNews

Lilly’s GLP-1 pill tops Novo’s Rybelsus in head-to-head trial

AI heavyweights call for end to ‘superintelligence’ research

No, ICE (Probably) Didn’t Buy Guided Missile Warheads

No, ICE (Probably) Didn’t Buy Guided Missile Warheads

Leave a Reply Cancel reply

RECOMMENDED NEWS

Govt apologises over national grid collapse, to empower states on power decentralisation – EnviroNews

Hong Kong Crypto Licenses Advance Amid BRICS Dollar Shift

PANDEF backs oil sector reforms, calls for Niger Delta inclusion – EnviroNews

Eni plans CCUS satellite following Ithaca success

POPULAR NEWS

Ghana to build three oil refineries, five petrochemical plants in energy sector overhaul

The world’s top 10 most valuable car brands in 2025

Top 10 African countries with the highest GDP per capita in 2025

Global ranking of Top 5 smartphone brands in Q3, 2024

Mahama attends Liberia’s 178th independence anniversary

Takeda stakes more than $11B on cancer drugs from China

Related posts

AI heavyweights call for end to ‘superintelligence’ research

No, ICE (Probably) Didn’t Buy Guided Missile Warheads

Leave a Reply Cancel reply

RECOMMENDED NEWS

POPULAR NEWS